SCM
IONS icon

Sio Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Sio Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-175,568
Closed -$6.5M – 66
2022
Q1 		$6.5M Sell
175,568
-146,998
-46% -$4.81M 2.15% 15
2021
Q4 		$9.82M Buy
+322,566
New +$10.2M 2.96% 13
2021
Q1 		– Sell
-81,026
Closed -$4.58M – 97
2020
Q4 		$4.58M Buy
+81,026
New +$4.04M 0.94% 33

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Sio Capital Management's IONS Position: Q2 2022 in Review

Sio Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2022, closing a stake of 175,568 shares — an estimated $6.5M sold.

Sio Capital Management first reported a position in IONS in Q4 2020 and held it in 3 quarters. The position peaked at $9.82M in Q4 2021. 350 funds tracked by Wall St. Rank hold IONS as of Q2 2022.

  • Sio Capital Management reported no remaining Ionis Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Sio Capital Management sold 175,568 Ionis Pharmaceuticals shares in Q2 2022, an estimated $6.5M.
  • Sio Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Sio Capital Management's Ionis Pharmaceuticals position peaked at $9.82M in Q4 2021.
  • 350 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2022.

Based on Sio Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.